Pulse Biosciences, Inc.
PLSE
$21.20
$0.271.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.07% | -1.13% | -14.13% | 13.36% | -52.88% |
| Total Depreciation and Amortization | 1.17% | -6.23% | -3.53% | -1.39% | -2.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.01% | 8.25% | -8.66% | -26.43% | 158.95% |
| Change in Net Operating Assets | -883.09% | -47.39% | 133.42% | -220.52% | 487.37% |
| Cash from Operations | -13.16% | -1.81% | 5.28% | -47.87% | -1.33% |
| Capital Expenditure | -69.35% | 39.81% | -128.89% | 15.09% | -39.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | -69.35% | 49.59% | -173.33% | 15.09% | -39.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -80.62% | -- | -100.00% | -69.32% | -21.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -205.36% |
| Cash from Financing | -80.62% | -- | -100.00% | -69.28% | -22.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.03% | 13.88% | -1,141.90% | -96.82% | -26.18% |